Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T11:16:20.602Z.
Calculation as of: 2026-10-06T11:16:20.602Z.
Quote observation: 2026-10-05T17:49:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 015f4768d679608bc4b6bcfba81ca244afda57a14a617ca6285ea64adc9468bc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$264.62M
EV/FCF Ratio
N/A
| NAME | MARKET CAP | EV/FCF RATIO |
|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $264.62M | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.32M | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $262.30M | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.51M | N/A |
| Cartesian Growth Corp. Iv (CGCF)vs › | $269.77M | N/A |
| Armada Acquisition Corp. III (AACI)vs › | $257.77M | N/A |
| Cantor Equity Partners Vii Inc. (CAES)vs › | $257.28M | N/A |
| Isabella Bank Corporation (ISBA)vs › | $277.68M | N/A |
| Cambridge Acquisition Corp. Class A Ordinary Shares (CAQ)vs › | $249.84M | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
